Waterjet-assisted Liposuction reduces inflammation but increases the risk of hypokalemia when compared to conventional tumescent liposuction in patients with lipedema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034711

Enrollment

Registered

2024-07-19

Start date

2024-02-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E88.21

Interventions

Group 1: Group 1 is characterized by patients with lipedema stage 2 or 3 who have had a conventionally performed tumescence liposuction between January 2018 and January 2024. Pre- and postoperative we

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients with lipedema stage 2 and 3

Exclusion criteria

Exclusion criteria: patients with immunological or chronical renal diseases and a BMI above 35 kg/m2

Design outcomes

Primary

Measure	Time frame
January 2024 patients who had liposuction between january 2018 and January 2024 are included pre- and postoperative the following parameters were measured: hematocrit hemoglobine leucocytes thrombocytes sodium potassium	—

Secondary

Measure	Time frame
15th July 2024 till 15th July 2024 relevant data of patients treated between January 2018 - January 2024 was collected	—

Countries

Germany

Contacts

Public ContactKatharina Jäckle

Universitätsmedizin Göttingen

katharina.jaeckle@med.uni-goettingen.de0551/3965422

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026